HHT is an autosomal dominant condition, with more than 80% of the cases associated with a mutation in either the ENG (endoglin) gene, which results in HHT type 1, or the ACVRL1 gene, which results in HHT type 2 [9]. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.